These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35115301)

  • 1. Metformin and risk of age-related macular degeneration in individuals with type 2 diabetes: a retrospective cohort study.
    Gokhale KM; Adderley NJ; Subramanian A; Lee WH; Han D; Coker J; Braithwaite T; Denniston AK; Keane PA; Nirantharakumar K
    Br J Ophthalmol; 2023 Jul; 107(7):980-986. PubMed ID: 35115301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Metformin Use With Age-Related Macular Degeneration: A Case-Control Study.
    Blitzer AL; Ham SA; Colby KA; Skondra D
    JAMA Ophthalmol; 2021 Mar; 139(3):302-309. PubMed ID: 33475696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Diabetes Medication With Open-Angle Glaucoma, Age-Related Macular Degeneration, and Cataract in the Rotterdam Study.
    Vergroesen JE; Thee EF; Ahmadizar F; van Duijn CM; Stricker BH; Kavousi M; Klaver CCW; Ramdas WD
    JAMA Ophthalmol; 2022 Jul; 140(7):674-681. PubMed ID: 35587864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin Use and Age-Related Macular Degeneration in Patients Without Diabetes.
    Aggarwal S; Moir J; Hyman MJ; Kaufmann GT; Flores A; Hariprasad SM; Skondra D
    JAMA Ophthalmol; 2024 Jan; 142(1):53-57. PubMed ID: 38019527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between metformin use and the risk of age-related macular degeneration in patients with type 2 diabetes: a retrospective study.
    Jiang J; Chen Y; Zhang H; Yuan W; Zhao T; Wang N; Fan G; Zheng D; Wang Z
    BMJ Open; 2022 Apr; 12(4):e054420. PubMed ID: 35473747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Common Antidiabetic Drug Metformin Reduces Odds of Developing Age-Related Macular Degeneration.
    Brown EE; Ball JD; Chen Z; Khurshid GS; Prosperi M; Ash JD
    Invest Ophthalmol Vis Sci; 2019 Apr; 60(5):1470-1477. PubMed ID: 30973575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of metformin and development of dry age-related macular degeneration in a U.S. insurance claims database.
    Eton EA; Wubben TJ; Besirli CG; Hua P; McGeehan B; VanderBeek BL
    Eur J Ophthalmol; 2022 Jan; 32(1):417-423. PubMed ID: 33607930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Metformin With the Development of Age-Related Macular Degeneration.
    Domalpally A; Whittier SA; Pan Q; Dabelea DM; Darwin CH; Knowler WC; Lee CG; Luchsinger JA; White NH; Chew EY;
    JAMA Ophthalmol; 2023 Feb; 141(2):140-147. PubMed ID: 36547967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incident dementia risk among patients with type 2 diabetes receiving metformin versus alternative oral glucose-lowering therapy: an observational cohort study using UK primary healthcare records.
    Doran W; Tunnicliffe L; Muzambi R; Rentsch CT; Bhaskaran K; Smeeth L; Brayne C; Williams DM; Chaturvedi N; Eastwood SV; Dunachie SJ; Mathur R; Warren-Gash C
    BMJ Open Diabetes Res Care; 2024 Jan; 12(1):. PubMed ID: 38272537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes, metformin use and risk of non-Hodgkin's lymphoma in postmenopausal women: A prospective cohort analysis in the Women's Health Initiative.
    Wang Z; Phillips LS; Rohan TE; Ho GYF; Shadyab AH; Bidulescu A; Rudick CN; Pan K; Chen Z; Luo J
    Int J Cancer; 2023 Apr; 152(8):1556-1569. PubMed ID: 36444502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative risk of major cardiovascular events associated with second-line antidiabetic treatments: a retrospective cohort study using UK primary care data linked to hospitalization and mortality records.
    Zghebi SS; Steinke DT; Rutter MK; Emsley RA; Ashcroft DM
    Diabetes Obes Metab; 2016 Sep; 18(9):916-24. PubMed ID: 27177784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-world antidiabetic drug use and fracture risk in 12,277 patients with type 2 diabetes mellitus: a nested case-control study.
    Losada E; Soldevila B; Ali MS; Martínez-Laguna D; Nogués X; Puig-Domingo M; Díez-Pérez A; Mauricio D; Prieto-Alhambra D
    Osteoporos Int; 2018 Sep; 29(9):2079-2086. PubMed ID: 29860664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Metformin, Other Antidiabetic Medications, and Statins With Incidence of Colon Cancer in Patients With Type 2 Diabetes.
    Erkinantti S; Marttila M; Sund R; Arffman M; Urpilainen E; Puistola U; Hautakoski A; Karihtala P; Läärä E; Jukkola A
    Clin Colorectal Cancer; 2021 Jun; 20(2):e113-e119. PubMed ID: 33279415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effectiveness and safety of sodium-glucose cotransporter-2 inhibitors versus metformin in patients with type 2 diabetes: An observational study using data from routine care.
    Fralick M; Schneeweiss S; Redelmeier DA; Razak F; Gomes T; Patorno E
    Diabetes Obes Metab; 2021 Oct; 23(10):2320-2328. PubMed ID: 34169619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.
    Ou HT; Chang KC; Li CY; Wu JS
    Cardiovasc Diabetol; 2016 Mar; 15():41. PubMed ID: 26932742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin.
    Bowker SL; Majumdar SR; Veugelers P; Johnson JA
    Diabetes Care; 2006 Feb; 29(2):254-8. PubMed ID: 16443869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative cardiovascular risks of dipeptidyl peptidase 4 inhibitors with other second- and third-line antidiabetic drugs in patients with type 2 diabetes.
    Ou HT; Chang KC; Li CY; Wu JS
    Br J Clin Pharmacol; 2017 Jul; 83(7):1556-1570. PubMed ID: 28109184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between oral metformin use and the risk of age-related macular degeneration: A systematic review with meta-analysis.
    Holtz JK; Thinggaard BS; Grauslund J; Subhi Y
    Acta Ophthalmol; 2023 Sep; 101(6):595-605. PubMed ID: 36876510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. INTERACTIONS OF METFORMIN AND OTHER MEDICATIONS IN REDUCING THE ODDS OF AGE-RELATED MACULAR DEGENERATION IN A COHORT OF PATIENTS WITH DIABETES.
    Shaw L; Khanna S; Hyman MJ; Ham S; Blitzer A; Parvar SP; Soo J; Flores A; Hariprasad S; Skondra D
    Retina; 2024 Feb; 44(2):197-204. PubMed ID: 37782954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Statins, Metformin, Angiotensin-Converting Enzyme Inhibitors, and Angiotensin II Receptor Blockers on Age-Related Macular Degeneration.
    Lee H; Jeon HL; Park SJ; Shin JY
    Yonsei Med J; 2019 Jul; 60(7):679-686. PubMed ID: 31250582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.